Literature DB >> 18707764

Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.

P Dammert1, B Bustamante, E Ticona, A Llanos-Cuentas, L Huaroto, V M Chávez, P E Campos.   

Abstract

OBJECTIVES: To describe the mycologic and clinical outcomes and factors associated with failure in Peruvian patients with AIDS-associated cryptococcal meningitis (CM) treated with amphotericin B deoxycholate (Amph B) followed by fluconazole.
METHODS: Patients were treated with intravenous Amph B 0.7 mg/kg/day for 2 or 3 weeks followed by oral fluconazole 400mg/day for 7 or 8 weeks. Clinical and laboratory evaluations including cerebrospinal fluid (CSF) studies were performed at baseline and at weeks 2 and 10.
RESULTS: The CSF cultures were negative in 25% and 68% of 47 patients at weeks 2 and 10, respectively. In the univariate analysis, baseline low body mass index (BMI), hyponatremia, low serum albumin, positive blood culture and CSF antigen titers >or=1024 were associated with a positive CSF culture at week 2. Baseline positive urine culture, positive blood culture, any positive extraneural culture and CSF opening pressure at week 2 >or=300 mm H2O were associated with a positive CSF culture at week 10. In the multivariate analysis no association was found.
CONCLUSIONS: Therapy with Amph B and fluconazole, combined with aggressive management of elevated intracranial pressure (ICP), results in low CSF sterilization rates at week 2 and acceptable CSF sterilization rates at week 10 when compared with other series.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707764     DOI: 10.1016/j.jinf.2008.06.020

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.

Authors:  Erika Nascimento; Lucia H Vitali; Ludmilla Tonani; Marcia R Von Zeska Kress; Osvaldo M Takayanagui; Roberto Martinez
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

2.  A fatal case of AIDS-defining meningoencephalitis by C. neoformans, sensitive to antifungal therapy.

Authors:  S Mohammad-Khani; B Otremba; R Klein; H H Capelle; F Logemann; F C Bange; R E Schmidt; M Stoll
Journal:  Eur J Med Res       Date:  2010-11-25       Impact factor: 2.175

Review 3.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

4.  Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis.

Authors:  Delio José Mora; Laila Rigolin Fortunato; Leonardo Eurípedes Andrade-Silva; Kennio Ferreira-Paim; Ivonete Helena Rocha; Rakel Rocha Vasconcelos; David Nascimento Silva-Teixeira; Gabriel Antonio Nogueira Nascentes; Mario León Silva-Vergara
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.

Authors:  Fátima Concha-Velasco; Elsa González-Lagos; Carlos Seas; Beatriz Bustamante
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 6.  Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.

Authors:  Jose E Vidal; Augusto C Penalva de Oliveira; Rafi F Dauar; David R Boulware
Journal:  Braz J Infect Dis       Date:  2013-05-10       Impact factor: 1.949

Review 7.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

Review 8.  The status of cryptococcosis in Latin America.

Authors:  Carolina Firacative; Jairo Lizarazo; María Teresa Illnait-Zaragozí; Elizabeth Castañeda
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-04-05       Impact factor: 2.743

9.  Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-Old.

Authors:  John Howard; Thomas Z Thompson; Rodger D MacArthur; Amyn M Rojiani; Joseph White
Journal:  Am J Case Rep       Date:  2020-10-12

Review 10.  Treatment of cryptococcal meningitis in resource limited settings.

Authors:  Derek J Sloan; Martin J Dedicoat; David G Lalloo
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.